On September 18, IBM fell 3.03% in regular trading, trading at $230.31 per share, with turnover of $384 million. The decline came as the global semiconductor selloff continued to reverberate across technology names, compounded by lingering concerns over IBM's earlier earnings disappointment.
On the news front, the global semiconductor and AI computing hardware sectors have been hit by a rare synchronized selloff triggered by prominent AI industry leaders publicly calling for a slowdown in frontier model development. The Philadelphia Semiconductor Index previously plunged nearly 6% in a single session, erasing over $500 billion in total market capitalization across the chip supply chain. Although a brief technical rebound occurred in the prior session, selling pressure has not fully subsided.
Adding to the headwinds, IBM previously suffered a $68 billion market cap wipeout after its Z-series product line significantly missed earnings expectations, prompting a formal regulatory investigation. Market confidence remains in a recovery phase. Meanwhile, the confirmation of a $1 billion CHIPS Act award for IBM subsidiary Anderon to advance its U.S.-based quantum foundry has failed to offset the broader systemic selling pressure.
Within the IT Consulting and Other Services sector, the overall industry remained under pressure. Among individual stocks, Quantinuum fell 4.32%, Accenture fell 3.34%, Kyndryl fell 3.13%, Cognizant fell 2.23%, and Gartner fell 1.96%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments